Literature DB >> 16107989

A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment.

Adriana S A Andrade1, Henraya F McGruder, Albert W Wu, Shivaun A Celano, Richard L Skolasky, Ola A Selnes, I-Chan Huang, Justin C McArthur.   

Abstract

Background. Patients cite "forgetting" as a reason for nonadherence to highly active antiretroviral therapy (HAART). We measured the effect of a memory-prompting device on adherence to HAART in memory-intact and memory-impaired human immunodeficiency virus (HIV)-infected subjects.Methods. The study was a prospective, randomized, controlled trial involving 64 HIV-infected adults. The intervention was the Disease Management Assistance System (DMAS) device, combined with monthly adherence counseling. Control subjects received only adherence counseling. The DMAS was programmed with HAART regimen data to provide verbal reminders at dosing times. Adherence was measured for 24 weeks using electronic drug exposure monitor (eDEM) caps.Results. A total of 58 subjects completed the 24-week study period; 28 were HAART naive (12 DMAS users and 16 control subjects). Mean adherence scores did not differ significantly between DMAS users (80%) and control subjects (65%). Post hoc analysis of 31 memory-impaired subjects (14 DMAS users and 17 control subjects) revealed significantly higher adherence rates among DMAS users (77%), compared with control subjects (57%) (P=.001). However, analysis of memory-intact subjects showed that adherence was not significantly improved for DMAS users (83%), compared with control subjects (77%) (P=.25). At week twelve, 38% of the DMAS users and 14% of the control subjects had an undetectable plasma HIV RNA load (P=.014), and at week 24, the plasma HIV RNA load was undetectable for 34% of the DMAS users and 38% of the control subjects (P=.49). CD4(+) cell counts did not differ between the study arms. Virological and immunological responses were not related to DMAS use in memory-impaired subjects.Conclusion. The DMAS prompting device improved adherence for memory-impaired subjects but not for memory-intact subjects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107989     DOI: 10.1086/432877

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  60 in total

1.  Two-way text messaging for health behavior change among human immunodeficiency virus-positive individuals.

Authors:  Lynne T Harris; Keren Lehavot; David Huh; Samantha Yard; Michele P Andrasik; Peter J Dunbar; Jane M Simoni
Journal:  Telemed J E Health       Date:  2010-11-18       Impact factor: 3.536

Review 2.  Rodent models for HIV-associated neurocognitive disorders.

Authors:  Santhi Gorantla; Larisa Poluektova; Howard E Gendelman
Journal:  Trends Neurosci       Date:  2012-02-01       Impact factor: 13.837

3.  Psychosocial Correlates of Medication Adherence among HIV-Positive, Cognitively Impaired Individuals.

Authors:  Timothy J Arentsen; Stella Panos; April D Thames; J Natalie Arbid; Steven A Castellon; Charles H Hinkin
Journal:  J HIV AIDS Soc Serv       Date:  2016-09-23

4.  Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.

Authors:  David J Moore; Kaitlin Blackstone; Steven Paul Woods; Ronald J Ellis; J Hampton Atkinson; Robert K Heaton; Igor Grant
Journal:  AIDS Care       Date:  2012-04-24

Review 5.  The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature.

Authors:  Marcia Vervloet; Annemiek J Linn; Julia C M van Weert; Dinny H de Bakker; Marcel L Bouvy; Liset van Dijk
Journal:  J Am Med Inform Assoc       Date:  2012-04-25       Impact factor: 4.497

6.  SMSaúde: Evaluating Mobile Phone Text Reminders to Improve Retention in HIV Care for Patients on Antiretroviral Therapy in Mozambique.

Authors:  Dvora Joseph Davey; José António Nhavoto; Orvalho Augusto; Walter Ponce; Daila Traca; Alexandre Nguimfack; Cesar Palha de Sousa
Journal:  J Acquir Immune Defic Syndr       Date:  2016-10-01       Impact factor: 3.731

Review 7.  Attrition and related trends in scientific rigor: a score card for ART adherence intervention research and recommendations for future directions.

Authors:  K Rivet Amico; Jennifer J Harman; Megan A O'Grady
Journal:  Curr HIV/AIDS Rep       Date:  2008-11       Impact factor: 5.071

8.  Prospective memory and antiretroviral medication non-adherence in HIV: an analysis of ongoing task delay length using the memory for intentions screening test.

Authors:  Amelia J Poquette; David J Moore; Ben Gouaux; Erin E Morgan; Igor Grant; Steven Paul Woods
Journal:  J Int Neuropsychol Soc       Date:  2012-10-25       Impact factor: 2.892

Review 9.  Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S.-based studies, 1996-2011.

Authors:  Mahnaz R Charania; Khiya J Marshall; Cynthia M Lyles; Nicole Crepaz; Linda S Kay; Linda J Koenig; Paul J Weidle; David W Purcell
Journal:  AIDS Behav       Date:  2014-04

Review 10.  Text messaging-based smoking cessation intervention: a narrative review.

Authors:  Grace Kong; Daniel M Ells; Deepa R Camenga; Suchitra Krishnan-Sarin
Journal:  Addict Behav       Date:  2013-12-04       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.